Leukemia, Lymphoid
Showing 51 - 75 of 6,227
Understanding Chronic Lymphocytic Leukemia
Recruiting
- Chronic Lymphocytic Leukemia
-
Boston, MassachusettsDana Farber Cancer Institute
Aug 1, 2022
B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,
Active, not recruiting
- B-Lymphoid Malignancies
- +3 more
- Fludarabine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 1, 2022
Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)
Recruiting
- Acute Lymphoblastic Leukemia
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 2, 2023
Side Effects of Curative Treatments of Lymphoblastic Leukemia in
Not yet recruiting
- Lymphoblastic Leukemia
- osteopathy
-
Paris, FranceRobert Debré Hospital
Dec 16, 2022
Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)
Completed
- Acute Lymphoblastic Leukemia
- Blinatumomab
- Hematopoietic Cell Transplantation
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 30, 2022
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- Acute Lymphoblastic Leukemia
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- inotuzumab ozogamicin
- (no location specified)
Jan 6, 2023
Acute Lymphoblastic Leukemia, Adult, Invasive Fungal Infections Trial in Rome (observation of invasive fungal infections)
Recruiting
- Acute Lymphoblastic Leukemia, Adult
- Invasive Fungal Infections
- observation of invasive fungal infections
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Feb 20, 2023
Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)
Not yet recruiting
- Lymphoproliferative Disorders
- +3 more
- No intervention
- (no location specified)
Jan 30, 2023
Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
- (no location specified)
Dec 27, 2022
Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Observation
- (no location specified)
Oct 12, 2023
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoid Leukemia Trial in Beijing
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- chimeric antigen receptor T cell
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Aug 12, 2022
B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)
Recruiting
- B-Cell Non Hodgkin Lymphoma
- B-Cell Acute Lymphoblastic Leukemia
- anti-CD19 CAR T-cells
-
Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology
Sep 5, 2023
Determination of Blood Tumor Cells
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Abnormalities Cell Epithelial
-
Zurich, SwitzerlandUniversity Hospital Zurich
Jan 9, 2023
Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)
Completed
- Lymphoid Leukemia
- +2 more
- Bendamustine
- +2 more
-
Madison, WisconsinUniversity of Wisconsin
Jan 30, 2023
B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Azacitidine Injection
- +2 more
- (no location specified)
Oct 15, 2023
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- CD19/CD22-bispecific CAR-T cells
-
Beijing, Beijing, ChinaLiang Wang
Oct 7, 2023
Acute T-lymphoblastic Leukemia, Acute T-lymphoblastic Lymphoma Trial in Xuzhou (CAR-T Cell Infusion)
Recruiting
- Acute T-lymphoblastic Leukemia
- Acute T-lymphoblastic Lymphoma
- CAR-T Cell Infusion
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023
Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)
Not yet recruiting
- Relapsed/Refractory Large Granular T Lymphocytic Leukemia
-
Zhoukou, Henan, China
- +1 more
Dec 22, 2022
Acute Lymphoblastic Leukemia, Obesity Trial in New York (PEDALL, Standard of care)
Recruiting
- Acute Lymphoblastic Leukemia
- Obesity
- PEDALL
- Standard of care
-
New York, New YorkColumbia University Medical Center
Jul 19, 2023
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +5 more
- Cyclophosphamide
- +2 more
-
São Paulo, BrazilHospital Israelita Albert Einstein
Jan 20, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- TQB3909 tablet
-
Zhengzhou, Henan, China
- +1 more
Jul 17, 2023
Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)
Active, not recruiting
- Leukemia
- Acute Lymphoblastic Leukemia
- gene-modified T cells targeted
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 1, 2023
Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal
Not yet recruiting
- Lymphoblastic Leukemia in Children
- induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
- +7 more
- (no location specified)
Oct 24, 2023
KCTD Protein Family in Clinical Management of Childhood Acute
Recruiting
- Childhood Acute Lymphoblastic Leukemia
- observational study
-
Naples, ItalyIRCCS Synlab SDN
Feb 6, 2023